ICD-10-CM · General

M33.29

Polymyositis with documented involvement of an organ system other than the respiratory tract or skeletal muscle — such as cardiac or gastrointestinal involvement.

Verified May 8, 2026 · 5 sources ↓

Status
Billable
Chapter
13
Related CPT
0
Region
General
Drawn from CDCicd10data.com FY2026ICDOutsourceStrategies: HowPMC

Documentation tips

What should appear in the chart to support M33.29.

Source · Editorial brief grounded in 5 cited references ↓

  • Identify the specific organ system involved beyond muscle and respiratory — cardiac (troponin level, echocardiography result) or GI (modified barium swallow findings, dysphagia description) must be named explicitly in the note.
  • Record the diagnostic basis for polymyositis itself: muscle biopsy pathology, EMG results, serum CK/aldolase values, and relevant autoantibody panel results (e.g., anti-Jo-1).
  • If dysphagia is the trigger for M33.29, document the confirmatory swallow study result and link it explicitly to the underlying inflammatory myopathy diagnosis in the assessment/plan.
  • When cardiac involvement is the basis, include troponin values, EKG findings, or echocardiogram results in the note — a general reference to 'cardiac symptoms' is insufficient for coding specificity.
  • Distinguish from respiratory involvement in the same encounter: if both pulmonary and cardiac involvement are documented, M33.21 and M33.29 are not combinable under a single M33.2 subcategory selection — apply the code that reflects the primary documented organ involvement and consider additional codes for secondary manifestations.

Common coding pitfalls

The recurring mistakes coders make with M33.29 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Defaulting to M33.29 when organ involvement is vague or presumed but not confirmed — if the note lacks objective findings for a specific organ system, the correct code is M33.20 (organ involvement unspecified), not M33.29.
  • Confusing M33.29 with M33.22: myopathy is its own subcode (M33.22); do not use M33.29 to capture muscle involvement — reserve M33.29 for non-respiratory, non-skeletal-muscle organ systems.
  • Using parent code M33.2 (Polymyositis) as a billable code when a more specific subcategory applies — M33.2 is a header; M33.29 is the billable code.
  • Failing to add secondary diagnosis codes for the specific organ manifestation (e.g., a separate code for cardiomyopathy or dysphagia) when payer policy or clinical documentation supports it — M33.29 alone may not fully capture the clinical picture for DRG or quality reporting purposes.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

M33.29 is the correct code when a patient has a confirmed polymyositis diagnosis and documentation supports involvement of an organ system that is neither respiratory (M33.21) nor limited to skeletal muscle myopathy (M33.22). Classic triggering presentations include cardiac involvement evidenced by elevated troponin or cardiomyopathy findings, or gastrointestinal involvement such as dysphagia confirmed by modified barium swallow study. If organ involvement is present but unspecified or not documented, drop to M33.20.

Within the M33.2 subcategory, code selection is driven entirely by documented organ involvement. M33.29 is a residual 'other' bucket — it covers everything except respiratory (M33.21) and myopathy-predominant (M33.22) presentations. Do not default to M33.29 as a catch-all; the specific organ system must be identified and documented in the clinical record. Undifferentiated or vague references to systemic illness without organ-specific findings belong at M33.20.

Polymyositis sits in Chapter 13 (M00–M99) under Dermatopolymyositis (M33). Because ICD codes for inflammatory myopathy have known limitations as a diagnostic surrogate — as noted in peer-reviewed systematic review literature — payer audits increasingly scrutinize supporting documentation: biopsy pathology, lab values, imaging, and specialist notes. Coding to the highest specificity (M33.29 over M33.20) directly supports appropriate DRG assignment and reduces the risk of downcoding on audit.

Sibling codes

Other billable codes under M33.2 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 5 cited references ↓

01What distinguishes M33.29 from M33.20?
M33.20 is used when organ involvement exists but is not specified in the documentation. M33.29 requires documentation of a specific organ system — such as cardiac or gastrointestinal — being involved, confirmed by objective findings like troponin elevation or a positive modified barium swallow.
02Can M33.29 be used for cardiac involvement in polymyositis?
Yes. Cardiac involvement — documented by elevated troponin, cardiomyopathy on echocardiogram, or arrhythmia attributable to the inflammatory myopathy — is a primary basis for M33.29. The cardiac findings must be explicitly documented and linked to the polymyositis diagnosis.
03Can M33.29 and M33.21 be coded together on the same claim?
No. M33.21 and M33.29 are mutually exclusive subcategories of M33.2 — you select one code that reflects the primary documented organ involvement. If multiple organ systems are involved, assign additional codes for secondary manifestations separately as appropriate.
04Is dysphagia a valid basis for M33.29?
Yes. Dysphagia confirmed by objective testing such as a modified barium swallow study, documented as a manifestation of the inflammatory myopathy, supports M33.29. A subjective complaint of difficulty swallowing without confirmatory study is insufficient on its own.
05What happens if I use M33.2 instead of M33.29?
M33.2 is a non-billable header code. Claims submitted with M33.2 as the diagnosis will be rejected or denied. Always code to the most specific subcategory — M33.29 when other organ involvement is documented.
06Should I add secondary codes alongside M33.29?
Yes, when payer policy and documentation support it. Secondary codes for specific manifestations — such as a code for cardiomyopathy or esophageal dysmotility — provide additional clinical detail that supports DRG assignment and quality reporting. M33.29 alone may not fully represent the encounter complexity.
07Is M33.29 valid for FY2026 dates of service?
Yes. M33.29 is an active, billable code in the FY2026 ICD-10-CM code set effective October 1, 2025, with no status changes from the prior year.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

  1. 01CDC ICD-10-CM Tabular List 2026 — https://icd10cmtool.cdc.gov/
  2. 02icd10data.com FY2026 — https://www.icd10data.com/ICD10CM/Codes/M00-M99/M30-M36/M33-/M33.29
  3. 03ICDcodes.ai Polymyositis Documentation Guide — https://icdcodes.ai/diagnosis/polymyositis/documentation
  4. 04OutsourceStrategies: How to Code for Dermatomyositis — https://www.outsourcestrategies.com/blog/code-dermatomyositis-common-rheumatology-disorder/
  5. 05PMC: Identification of IIM Research Cohorts Using ICD Codes, Systematic Review — https://pmc.ncbi.nlm.nih.gov/articles/PMC12547942/

Mira AI Scribe

Mira AI Scribe captures the organ system driving the 'other involvement' designation — troponin values with date drawn, echocardiogram findings, or modified barium swallow results confirming dysphagia — along with the polymyositis diagnostic basis (biopsy pathology, CK level, autoantibody status). This prevents the encounter from defaulting to M33.20 (unspecified organ involvement), which carries lower DRG weight and flags for specificity-related audit review.

See how Mira captures M33.29 documentation

Related ICD-10 codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free